Novartis

Novartis sells US rights to three COPD drugs
BioPharma Dive
Thu, 12/22/16 - 10:05 am
Novartis
COPD
Sunovion
Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout
Endpoints
Fri, 12/16/16 - 11:34 am
Novartis
eczema
dermatology
M&A
ZPL389
Ziarco
Novartis' Big News at ASH? It's Still in the CAR-T Race
Motley Fool
Fri, 12/16/16 - 11:28 am
Novartis
ASH
CAR-T
CTL-019
Don't Buy The Depomed Buyout Rumors; Buy The Certainty Of An Eventual Deal
Seeking Alpha
Thu, 12/8/16 - 11:13 pm
Depomed
Novartis
M&A
Has GlaxoSmithKline Finally Turned the Corner?
Motley Fool
Tue, 12/6/16 - 09:43 am
GSK
Novartis
Breo Ellipta
Anoro Ellipta
Novartis Makes Its Case For Driving A CAR Into The Real World
Seeking Alpha
Mon, 12/5/16 - 10:43 pm
Novartis
CAR-T
Kite Pharma
CTL019
KTE-C19
Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?
Fierce Pharma
Mon, 12/5/16 - 10:10 am
DTC advertising
psoriasis
Eli Lilly
Novartis
Taltz
Cosentyx
What makes a PhII drug worth up to $665M? Researchers spell it out for Novartis
Endpoints
Mon, 12/5/16 - 09:48 am
Novartis
crizanlizumab
sickle cell disease
M&A
Selexys
Novartis CEO plays down prospects for Actelion bid
Yahoo/Reuters
Sun, 12/4/16 - 12:33 pm
Novartis
Actelion
M&A
Pharma CEOs
Joe Jimenez
In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program
Endpoints
Sun, 12/4/16 - 12:24 pm
Novartis
CAR-T
CTL019
B-cell acute lymphoblastic leukemia
Novartis donates $10M in generics to global relief
BioPharma Dive
Mon, 11/28/16 - 11:29 pm
Novartis
generics
philanthropy
Sandoz
Novartis Social Media Network for Patients - Is This a Good Idea
CP Wire
Mon, 11/28/16 - 01:13 pm
Novartis
social media
heart failure
Novartis Unveils Heart Failure Social Network
Investopedia
Sun, 11/27/16 - 04:02 pm
Novartis
heart failure
social media
Novartis’ recently departed oncology R&D chief is headed back to Dana-Farber and a new job in cancer research
Endpoints
Wed, 11/23/16 - 10:18 am
Novartis
oncology
R&D
Chiesi buys asthma company, pitting it against Novartis
BioPharma Dive
Tue, 11/22/16 - 11:26 am
Chiesi
asthma
Novartis
Atopix Therapeutics
Novartis buys sickle cell player Selexys in $665M deal
Fierce Biotech
Mon, 11/21/16 - 11:34 am
Novartis
Selexys
M&A
sickle cell disease
Novartis’s Alcon Continues Its Falling Trend in 3Q16
Market Realist
Fri, 11/18/16 - 10:10 am
Novartis
Alcon
eye health
Drug Makers Target Psoriatic Arthritis
Investopedia
Thu, 11/17/16 - 04:44 pm
psoriatic arthritis
Novartis
Celgene
Otezla
Cosentyx
Novartis’s Revenue Trend in 3Q16
Market Realist
Thu, 11/17/16 - 09:32 am
Novartis
earnings
Novartis May Buy Generics Maker Amneal for $8B
Investopedia
Wed, 11/16/16 - 09:48 am
Novartis
Amneal
generics
eye health
M&A

Pages